Impact Biomedical (IBO) Debt Ratio (2023 - 2025)
Impact Biomedical's (IBO) quarterly Debt Ratio came in at 1.26 in Q3 2025, up 636.16% YoY from 0.17 in Q3 2024, and up 7.16% on a QoQ basis from 1.17 in Q2 2025.
Impact Biomedical (IBO) Debt Ratio (2023 - 2025) Analysis & Trends
Impact Biomedical (IBO) has 3 years of Debt Ratio data on file, last reported at 1.26 in Q3 2025.
- Quarterly Debt Ratio rose 636.16% year-over-year to 1.26 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 1.26 (up 636.16% YoY) and the FY2024 annual result came in at 0.44, up 61.75% from the prior year.
- Debt Ratio improved to 1.26 in Q3 2025, from 1.17 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 1.26 in Q3 2025 to a low of 0.17 in Q3 2024.
- A 3-year average of 0.63 and a median of 0.45 in 2024 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2024 — Debt Ratio soared 61.75% — and 2025, when it jumped 636.16%.
- Tracing IBO's Debt Ratio over 3 years: stood at 0.27 in 2023, then soared by 61.75% to 0.44 in 2024, then surged by 187.2% to 1.26 in 2025.
- The last three Debt Ratio figures came in at 1.26 (Q3 2025), 1.17 (Q2 2025), and 0.46 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.26 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.47 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.03 |
| 10 | Impact Biomedical | 49.45 Mn | 49.44 Mn | 2,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.26 |
| Jun 30, 2025 | 1.17 |
| Mar 31, 2025 | 0.46 |
| Dec 31, 2024 | 0.44 |
| Sep 30, 2024 | 0.17 |
| Dec 31, 2023 | 0.27 |